China Universal Asset Management Company’s Aurinia Pharmaceuticals AUPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$347K Sell
20,467
-3,130
-13% -$50K 0.02% 299
2026
Q1
$350K Buy
23,597
+2,114
+10% +$30.9K 0.03% 298
2025
Q4
$343K Sell
21,483
-1,590
-7% -$22.5K 0.03% 290
2025
Q3
$255K Sell
23,073
-4,062
-15% -$44.4K 0.02% 314
2025
Q2
$230K Sell
27,135
-413
-1% -$3.31K 0.02% 297
2025
Q1
$221K Sell
27,548
-2,811
-9% -$22.8K 0.02% 304
2024
Q4
$273K Buy
30,359
+2,857
+10% +$23.3K 0.03% 304
2024
Q3
$202K Buy
27,502
+10,700
+64% +$66.3K 0.02% 299
2024
Q2
$95.9K Sell
16,802
-11,000
-40% -$57.9K 0.01% 304
2024
Q1
$139K Buy
27,802
+11,189
+67% +$75.9K 0.02% 337
2023
Q4
$149K Buy
16,613
+12,940
+352% +$107K 0.03% 239
2023
Q3
$28.5K Buy
3,673
+1,798
+96% +$17.6K 0.01% 272
2023
Q2
$18.1K Sell
1,875
-57
-3% -$592 0.01% 276
2023
Q1
$21.2K Buy
1,932
+488
+34% +$4.3K 0.01% 214
2022
Q4
$6.24K Buy
1,444
+116
+9% +$673 ﹤0.01% 271
2022
Q3
$10K Buy
+1,328
New +$11.5K ﹤0.01% 203

Other funds holding AUPH

China Universal Asset Management Company's AUPH Position: Q2 2026 in Review

China Universal Asset Management Company reduced its Aurinia Pharmaceuticals (AUPH) stake by 13% in Q2 2026, selling an estimated $50K and leaving 20,467 shares worth $347K. The position accounts for 0.02% of the portfolio, ranked #299.

China Universal Asset Management Company first reported a position in AUPH in Q3 2022 and has held it in 16 quarters since. The position peaked at $350K in Q1 2026. 48 funds tracked by Wall St. Rank hold AUPH as of Q2 2026.

  • China Universal Asset Management Company held 20,467 shares of Aurinia Pharmaceuticals worth $347K as of Q2 2026.
  • China Universal Asset Management Company sold 3,130 Aurinia Pharmaceuticals shares in Q2 2026, an estimated $50K.
  • Aurinia Pharmaceuticals made up 0.02% of China Universal Asset Management Company's portfolio in Q2 2026, its #299 holding.
  • China Universal Asset Management Company first reported a position in Aurinia Pharmaceuticals in Q3 2022 and has held it in 16 quarters since.
  • China Universal Asset Management Company's Aurinia Pharmaceuticals position peaked at $350K in Q1 2026.
  • 48 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q2 2026.

Based on China Universal Asset Management Company's 13F filing for Q2 2026, filed 24 Jul 2026.